Company
The Centre for Immunology & Infection (C2i) research programmes address significant public healthcare challenges through the establishment of a novel technology platform for biomarker discovery and the development of new vaccine and therapeutic strategies. C2i enhances Hong Kong’s knowledge-based economy, provide state-of-the-art training for the local population and advance health by improving the effectiveness of future public health policies.
